Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.25 (2.56%)
Spread: 1.00 (10.526%)
Open: 9.75
High: 10.00
Low: 9.75
Prev. Close: 9.75
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scancell raises £6.2m in placing and open offer

Mon, 04th Apr 2016 11:47

(ShareCast News) - Scancell revealed the final results of its placing and open offer on Monday, with a few more subscriptions received since the firm's last update on 1 April.The AIM-traded company had announced on Friday that it had received subscriptions for 16,048,593 new ordinary shares of the 22,495.068 available under the open offer.Monday's announcement said it had now received applications for an additional 558,823 new ordinary shares available, but not subscribed for by, qualifying shareholders under the open offer, taking the revised total subscription to 16,607,416 new ordinary shares, or 73.8% of those available."The company has therefore raised gross proceeds of approximately £2.8m through the open offer and £3.4m through the placing, being approximately £6.2m in total," Scancell's board said in a statement.Scancell said application was to be made for the 36,607,416 new shares to be admitted to trading on AIM, which was expected to occur at 0800 BST on 5 April.The board said the total number of ordinary shares following admission would be 261,558,099.
More News
20 Oct 2015 07:48

Scancell Expects SCIB1 Clinical Study Report In First Half Of 2016

Read more
13 Oct 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
18 Sep 2015 09:23

Bigger loss but positive drug trial results for Scancell Holdings

(ShareCast News) - Scancell Holdings's losses increased marginally in the year ended 30 April 2015. The cancer immunotherapy developer announced on Friday a wider loss of £2.414m from £2.222m last year. It comes as a result of expected additional expenditure on its SCIB1 ImmunoBody clinical trials

Read more
18 Sep 2015 07:49

Scancell Holdings Loss Wider On Higher Development Costs

Read more
30 Jul 2015 09:40

Scancell Signs Research Collaboration Deal With ImmunID

Read more
9 Jul 2015 08:57

Scancell Closes Patient Recruitment For Next Phase Of SCIB1 Trials

Read more
2 Jun 2015 12:19

Scancell gives positive update on melanoma treatment data

Biopharmaceutical company Scancell Holdings reported further encouraging results from the ongoing 'Phase 1/2' clinical trial of its melanoma treatment SCIB1, which it presented at the annual meeting of the American Society of Clinical Oncology in Chicago. The data showed that all 16 patients with re

Read more
2 Jun 2015 07:27

Scancell Reports Encouraging Ongoing SCIB1Trial Results

Read more
24 Mar 2015 10:21

Scancell Says New Data Supports SCIB2 Combination Treatment

Read more
12 Jan 2015 09:47

Scancell Sees Positive Data In On-Going Phase I/2 SCIB1Trial

Read more
14 Oct 2014 11:23

UK MIDDAY BRIEFING: Life's No Catwalk For Luxury Goods Makers

Read more
14 Oct 2014 11:09

UK WINNERS & LOSERS: Miners Continue Run, Oil Companies Fall

Read more
14 Oct 2014 07:44

Scancell Shares Boosted By Positive SCIB-1 Trial Results

Read more
14 Oct 2014 07:32

UK MORNING BRIEFING: Burberry And Hargreaves Lansdown Lead Declines

Read more
14 Oct 2014 05:22

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.